Literature DB >> 18288103

Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis.

D S C Raj1, P Moseley, E A Dominic, A Onime, A H Tzamaloukas, A Boyd, V O Shah, R Glew, R Wolfe, A Ferrando.   

Abstract

Increased demand for amino acids to sustain acute-phase protein synthesis could be the stimulus for the increased muscle protein catabolism during hemodialysis (HD). This could be attenuated by intradialytic amino-acid infusion. To test this, we measured the fractional synthesis rates of albumin, fibrinogen, and muscle protein in eight patients with end-stage renal disease at baseline before dialysis and during HD without or with amino-acid infusion. The percentage change in the fractional synthesis rates of albumin, fibrinogen, and muscle protein from baseline was significantly higher during HD with amino-acid infusion than without amino-acid infusion. Leg muscle proteolysis was significantly increased during unsupplemented HD compared with baseline, but this was not decreased by amino-acid infusion. Arteriovenous balance studies across the leg showed a net efflux of interleukin-6 (IL-6) from the muscle into the vein during HD. The fractional synthesis rate of albumin, fibrinogen, and muscle protein correlated with each other and with the IL-6 efflux from the leg. Leg muscle protein catabolism was positively related to IL-6 release from the leg and not associated with amino-acid availability. Our results show that intradialytic cytokine activation and not amino-acid depletion is the major protein catabolic signal during HD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288103     DOI: 10.1038/ki.2008.21

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  Electroacupuncture therapy for muscle atrophy in CKD: is there a needle in the haystack?

Authors:  Ali Ramezani; Ian R Barrows; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2014-09-16       Impact factor: 10.121

2.  Activation of caspase-3 in the skeletal muscle during haemodialysis.

Authors:  Michel A Boivin; Shadi I Battah; Elizabeth A Dominic; Kamyar Kalantar-Zadeh; Arny Ferrando; Antonios H Tzamaloukas; Rama Dwivedi; Thomas A Ma; Pope Moseley; Dominic S C Raj
Journal:  Eur J Clin Invest       Date:  2010-08-19       Impact factor: 4.686

3.  Inflammation and Progression of CKD: The CRIC Study.

Authors:  Richard L Amdur; Harold I Feldman; Jayanta Gupta; Wei Yang; Peter Kanetsky; Michael Shlipak; Mahboob Rahman; James P Lash; Raymond R Townsend; Akinlolu Ojo; Akshay Roy-Chaudhury; Alan S Go; Marshall Joffe; Jiang He; Vaidyanathapuram S Balakrishnan; Paul L Kimmel; John W Kusek; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

4.  Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.

Authors:  Wai W Cheung; Robert H Mak
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-22

5.  Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

Authors:  Dominic S C Raj; Juan J Carrero; Vallabh O Shah; Abdul R Qureshi; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Jennet Ferguson; Pope L Moseley; Peter Stenvinkel
Journal:  Am J Kidney Dis       Date:  2009-09-06       Impact factor: 8.860

6.  High Dose Omega-3 Fatty Acid Administration and Skeletal Muscle Protein Turnover in Maintenance Hemodialysis Patients.

Authors:  Serpil Muge Deger; Adriana M Hung; Charles D Ellis; Cindy Booker; Aihua Bian; Guanhua Chen; Naji N Abumrad; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-08       Impact factor: 8.237

7.  Low-frequency electrical stimulation attenuates muscle atrophy in CKD--a potential treatment strategy.

Authors:  Li Hu; Janet D Klein; Faten Hassounah; Hui Cai; Cong Zhang; Ping Xu; Xiaonan H Wang
Journal:  J Am Soc Nephrol       Date:  2014-09-16       Impact factor: 10.121

8.  Wasting in chronic kidney disease.

Authors:  Robert H Mak; Alp T Ikizler; Csaba P Kovesdy; Dominic S Raj; Peter Stenvinkel; Kamyar Kalantar-Zadeh
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-03-16       Impact factor: 12.910

9.  Mitochondrial DNA deletion and sarcopenia.

Authors:  Vallabh O Shah; John Scariano; Debra Waters; Clifford Qualls; Marilee Morgan; Gavin Pickett; Chuck Gasparovic; Karol Dokladny; Pope Moseley; Dominic S C Raj
Journal:  Genet Med       Date:  2009-03       Impact factor: 8.822

10.  Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.

Authors:  Mark Reinhard; Jan Frystyk; Bente Jespersen; Mette Bjerre; Jens S Christiansen; Allan Flyvbjerg; Per Ivarsen
Journal:  BMC Nephrol       Date:  2013-04-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.